Cardinal Health annual research report examines milestone year in biosimilars
Go back to Cardinal Health annual research report examines milestone year in biosimilars| Cardinal Health Inc. (NYSE: CAH) | Delayed: 230.11 -3.55 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $233.66 | 52 Week High | $91.22 | |||
| Open | $231.80 | 52 Week Low | $62.70 | |||
| Day High | $231.83 | P/E | 215.06 | |||
| Day Low | $227.85 | EPS | $1.07 | |||
| Volume | 3,127,439 | |||||

